Skip to content

Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients

Pecto-intercostal Fascial Block With Perineural Adjuvants for Postoperative Analgesia Following Sternotomy in Patients Undergoing Cardiac Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05676814
Enrollment
31
Registered
2023-01-09
Start date
2023-03-24
Completion date
2023-06-24
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Sternotomy

Keywords

Pecto-intercostal Fascial Block, Postoperative, Pain, Cardiac Surgery

Brief summary

The purpose of this randomized, triple-blinded, prospective, feasibility study is to compare postoperative analgesia provided by Pecto-intercostal Fascial Block (PIFB) when performed with local anesthetic solution with or without perineural adjuvants in patients following cardiac surgery involving sternotomy. The study team hypothesizes that the patients receiving PIFB with bupivacaine with epinephrine, clonidine, and dexamethasone will have lower dynamic pain over the first 36 hours compared to those receiving PIFB with just bupivacaine and epinephrine.

Detailed description

This will be a randomized, triple-blinded, prospective, feasibility trial. Written informed consent will be obtained from all study participants prior to randomization. Patients scheduled to undergo cardiac surgery involving sternotomy at Atrium Health Wake Forest Baptist will be screened for eligibility. These patients will be approached for enrollment by research staff either during their preoperative assessment clinic visit prior to their surgery date, or when admitted as inpatients and scheduled for surgery. Subjects chosen to participate will be randomized into one or other arm and PIFB will be performed after skin closure and before transport from the operating room to the ICU. For patients who are randomized at enrollment but later excluded due to exclusion criteria prior to block placement, their randomization assignment will be replaced at the end of the initial recruitment.

Interventions

DRUGPecto-intercostal Fascial Block (PIFB)

PIFB done with bupivacaine and epinephrine

DRUGPIFB with adjuvants

PIFB with bupivacaine, epinephrine, clonidine, and dexamethasone

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Patients will be blinded to their treatment arm assignment, as will all research personnel who be responsible for collection of outcome data, as well as the surgeons performing the procedure, and critical care staff caring for the patients in the postoperative period. The anesthesiologist who will be performing the Pecto-intercostal Fascial Block (PIFB) will open the envelope informing them of the arm assignment; they will be the only care providers unblinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Adults between undergoing cardiac surgery involving sternotomy

Exclusion criteria

* Patients with any contraindications to regional anesthesia, such as history of allergy to amide local anesthetics or any of the perineural adjuvants * existing neurologic deficit in the chest wall; * remaining intubated at the six hour point after block placement * weight under 50kg * undergoing emergency surgical procedures or urgent return to the operating room * active endocarditis or mediastinitis * moderate to severe right ventricular function before or after cardiopulmonary bypass * reliance on mechanical circulatory support devices, such as intra-aortic balloon pump or Impella * reliance on extracorporeal membrane oxygenation * localized or systemic infection * chronic use of high dose opioid analgesics (defined as daily use greater than 30 oral morphine milligram equivalents (OMME) for over one month prior to surgery) * those who are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores0 to 6 hours after block placementBased on patient-reported dynamic Numerical Rating Scale (NRS) pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 0 to 6 hrs after placement.

Secondary

MeasureTime frameDescription
Safety Outcome: Postoperative Delirium IncidenceUp to 36 hours after block placementAverage number of Delirium incidences
Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest6 hours after block placementPain scores range from 0 to 10 with higher scores denoting more pain.
Average Cumulative Opioid Consumption36 hours after block placementAverage Cumulative Opioid Consumption in milligrams
Average Time to First Opioid AdministrationUp to 36 hours after block placementAverage Time to First Opioid Administration - Postoperative after extubation measured in minutes
Safety Outcome: Vomiting IncidenceUp to 36 hours after block placementAverage number of Vomiting incidences
Duration of Intensive Care Unit (ICU) AdmissionUp to 52 hours after block placementDuration of Intensive Care Unit (ICU) Admission - measured in Average number of hours.
Incentive Spirometry Volumes6, 12, 18, 24 hours after block placementAn incentive spirometer is a handheld medical device that measures the volume of subject's breath. The volume of air displaced is indicated in milliliters on a scale located on the device enclosure. This device measures what is called vital capacity, the amount of air that is breathed in and out of the lungs.
Safety Outcome: Nausea IncidenceUp to 36 hours after block placementAverage number of incidences of Nausea
Numeric Rating Scale (NRS) Satisfaction With the Analgesic Regimen36 hours after block placementPatient-reported scores range from 0-10 where 0 represents completely unsatisfied and 10 represents completely satisfied.
Average Time to ExtubationUp to 36 hours after block placementAverage Time to Extubation - measured in minutes

Countries

United States

Participant flow

Participants by arm

ArmCount
Pecto-intercostal Fascial Block (PIFB)
Subjects in this arm receive standard of care PIFB after surgery Pecto-intercostal Fascial Block (PIFB): PIFB done with bupivacaine and epinephrine
16
PIFB With Adjuvants
Subjects in this arm receive standard of care PIFB with additional medications after surgery PIFB with adjuvants: PIFB with bupivacaine, epinephrine, clonidine, and dexamethasone
15
Total31

Baseline characteristics

CharacteristicPecto-intercostal Fascial Block (PIFB)PIFB With AdjuvantsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
12 Participants8 Participants20 Participants
Age, Categorical
Between 18 and 65 years
4 Participants7 Participants11 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants15 Participants31 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
15 Participants15 Participants30 Participants
Region of Enrollment
United States
16 Participants15 Participants31 Participants
Sex: Female, Male
Female
3 Participants1 Participants4 Participants
Sex: Female, Male
Male
13 Participants14 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 8
other
Total, other adverse events
0 / 120 / 8
serious
Total, serious adverse events
0 / 120 / 8

Outcome results

Primary

Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

Time frame: 18 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores4.00 scores on a scale*hourStandard Deviation 2.09
PIFB With AdjuvantsArea Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores5.12 scores on a scale*hourStandard Deviation 3.23
Primary

Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

Based on patient-reported dynamic Numerical Rating Scale (NRS) pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain. 0 to 6 hrs after placement.

Time frame: 0 to 6 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores6.39 scores on a scale*hourStandard Deviation 3.23
PIFB With AdjuvantsArea Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores4.22 scores on a scale*hourStandard Deviation 3.76
Primary

Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

Time frame: 12 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores3.28 scores on a scale*hourStandard Deviation 2.03
PIFB With AdjuvantsArea Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores4.06 scores on a scale*hourStandard Deviation 3.65
Primary

Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

Time frame: 36 hours after block placement

Population: data wasn't collected

Primary

Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores

Based on patient-reported dynamic NRS pain scores with incentive spirometer (IS) use in subjects that are extubated. Pain scores range from 0 to 10 with higher scores denoting more pain.

Time frame: 24 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores3.18 scores on a scale*hourStandard Deviation 2.19
PIFB With AdjuvantsArea Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores4.71 scores on a scale*hourStandard Deviation 3.06
Secondary

Average Cumulative Opioid Consumption

Average Cumulative Opioid Consumption in milligrams

Time frame: 36 hours after block placement

Population: data wasn't collected

Secondary

Average Time to Extubation

Average Time to Extubation - measured in minutes

Time frame: Up to 36 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Average Time to Extubation276.815 MinutesStandard Deviation 78.609
PIFB With AdjuvantsAverage Time to Extubation232.020 MinutesStandard Deviation 68.689
Secondary

Average Time to First Opioid Administration

Average Time to First Opioid Administration - Postoperative after extubation measured in minutes

Time frame: Up to 36 hours after block placement

Population: data not collected

Secondary

Duration of Intensive Care Unit (ICU) Admission

Duration of Intensive Care Unit (ICU) Admission - measured in Average number of hours.

Time frame: Up to 52 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Duration of Intensive Care Unit (ICU) Admission50.620 HoursStandard Deviation 32.302
PIFB With AdjuvantsDuration of Intensive Care Unit (ICU) Admission51.541 HoursStandard Deviation 59.249
Secondary

Incentive Spirometry Volumes

An incentive spirometer is a handheld medical device that measures the volume of subject's breath. The volume of air displaced is indicated in milliliters on a scale located on the device enclosure. This device measures what is called vital capacity, the amount of air that is breathed in and out of the lungs.

Time frame: 6, 12, 18, 24 hours after block placement

ArmMeasureGroupValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Incentive Spirometry Volumes24 hours1093.94 MillilitersStandard Deviation 337.25
Pecto-intercostal Fascial Block (PIFB)Incentive Spirometry Volumes6 hours525 MillilitersStandard Deviation 338.56
Pecto-intercostal Fascial Block (PIFB)Incentive Spirometry VolumesBaseline2750 MillilitersStandard Deviation 823.43
Pecto-intercostal Fascial Block (PIFB)Incentive Spirometry Volumes18 hours878.79 MillilitersStandard Deviation 336.08
Pecto-intercostal Fascial Block (PIFB)Incentive Spirometry Volumes12 hours968.06 MillilitersStandard Deviation 287.14
PIFB With AdjuvantsIncentive Spirometry Volumes24 hours1275 MillilitersStandard Deviation 498.65
PIFB With AdjuvantsIncentive Spirometry Volumes12 hours1519.44 MillilitersStandard Deviation 716.12
PIFB With AdjuvantsIncentive Spirometry Volumes18 hours1440.63 MillilitersStandard Deviation 794.07
PIFB With AdjuvantsIncentive Spirometry VolumesBaseline3427.08 MillilitersStandard Deviation 743.27
PIFB With AdjuvantsIncentive Spirometry Volumes6 hours1333.33 MillilitersStandard Deviation 857.97
Secondary

Numeric Rating Scale (NRS) Satisfaction With the Analgesic Regimen

Patient-reported scores range from 0-10 where 0 represents completely unsatisfied and 10 represents completely satisfied.

Time frame: 36 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Numeric Rating Scale (NRS) Satisfaction With the Analgesic Regimen7.92 units on a scaleStandard Deviation 1.98
PIFB With AdjuvantsNumeric Rating Scale (NRS) Satisfaction With the Analgesic Regimen8.88 units on a scaleStandard Deviation 0.99
Secondary

Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest

Pain scores range from 0 to 10 with higher scores denoting more pain.

Time frame: 6, 12, 18, 24 hours after block placement

ArmMeasureGroupValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest12 hour2.67 units on a scaleStandard Deviation 2.02
Pecto-intercostal Fascial Block (PIFB)Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest24 hour3.09 units on a scaleStandard Deviation 2.26
Pecto-intercostal Fascial Block (PIFB)Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest18 hour2.45 units on a scaleStandard Deviation 2.42
Pecto-intercostal Fascial Block (PIFB)Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest6 hour5.25 units on a scaleStandard Deviation 3.22
PIFB With AdjuvantsPatient-reported Numerical Rating Scale (NRS) Pain Scores at Rest12 hour3.14 units on a scaleStandard Deviation 3.18
PIFB With AdjuvantsPatient-reported Numerical Rating Scale (NRS) Pain Scores at Rest6 hour3.43 units on a scaleStandard Deviation 4.24
PIFB With AdjuvantsPatient-reported Numerical Rating Scale (NRS) Pain Scores at Rest18 hour3.5 units on a scaleStandard Deviation 3.25
PIFB With AdjuvantsPatient-reported Numerical Rating Scale (NRS) Pain Scores at Rest24 hour3.5 units on a scaleStandard Deviation 3.78
Secondary

Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest

Pain scores range from 0 to 10 with higher scores denoting more pain.

Time frame: 6 hours after block placement

ArmMeasureValue (MEAN)Dispersion
Pecto-intercostal Fascial Block (PIFB)Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest5.25 units on a scaleStandard Deviation 3.22
PIFB With AdjuvantsPatient-reported Numerical Rating Scale (NRS) Pain Scores at Rest3.43 units on a scaleStandard Deviation 4.24
Secondary

Safety Outcome: Nausea Incidence

Average number of incidences of Nausea

Time frame: Up to 36 hours after block placement

Population: data wasn't collected

Secondary

Safety Outcome: Postoperative Delirium Incidence

Average number of Delirium incidences

Time frame: Up to 36 hours after block placement

Population: data wasn't collected

Secondary

Safety Outcome: Vomiting Incidence

Average number of Vomiting incidences

Time frame: Up to 36 hours after block placement

Population: data wasn't collected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026